Adenylate cyclase‐activating polypeptide 1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer

Adenylate cyclase‐activating polypeptide 1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer

Bibliographic Details
Main Authors:	Wenhao Xu, Aihetaimujiang Anwaier, Wangrui Liu, Xi Tian, Yuanyuan Qu, Jianyuan Zhao, Hailiang Zhang, Dingwei Ye
Format:	Article
Language:	English
Published:	Wiley 2021-10-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.597

Similar Items

Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma
by: Aihetaimujiang Anwaier, et al.
Published: (2023-09-01)

Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment
by: Jianfeng Yang, et al.
Published: (2022-10-01)

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
by: Kun Chang, et al.
Published: (2022-12-01)

m6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-07-01)

Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer
by: Wenhao Xu, et al.
Published: (2022-07-01)

Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma
by: Wenhao Xu, et al.
Published: (2022-08-01)

Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-12-01)

Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response
by: Wenhao Xu, et al.
Published: (2021-01-01)

Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma
by: Wenhao Xu, et al.
Published: (2022-07-01)

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
by: Gabriella Horvath, et al.
Published: (2022-04-01)

Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
by: João C. R. Cardoso, et al.
Published: (2020-05-01)

On the existence of possible pituitary adenylate cyclase-activating polypeptide adenylate type 1 receptor in earthworms
by: L Molnár, et al.
Published: (2015-06-01)

On the existence of possible pituitary adenylate cyclase-activating polypeptide adenylate type 1 receptor in earthworms
by: L Molnár, et al.
Published: (2015-05-01)

Corrigendum: Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
by: João C. R. Cardoso, et al.
Published: (2020-08-01)

The unique genomic landscape and prognostic mutational signature of Chinese clear cell renal cell carcinoma
by: Wenhao Xu, et al.
Published: (2022-09-01)

Role of pituitary adenylate cyclase‐activating polypeptide in modulating hypothalamic‐pituitary system
by: Aki Oride, et al.
Published: (2018-07-01)

Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome.
by: Benedicte Eneman, et al.
Published: (2017-01-01)

Distribution and protective function of pituitary adenylate cyclase-activating polypeptide (PACAP) in the retina
by: Tomoya eNakamachi, et al.
Published: (2012-11-01)

A systematic review of current advancements of artificial intelligence in genitourinary cancers
by: XU Wenhao, TIAN Xi, Aihetaimujiang·Anwaier , QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei
Published: (2022-01-01)

Pituitary Adenylate Cyclase-Activating Polypeptide: A Potent Therapeutic Agent in Oxidative Stress
by: Nadia Sadanandan, et al.
Published: (2021-02-01)

Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease
by: Takahiro Hirabayashi, et al.
Published: (2022-01-01)

Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice
by: Satoko eHattori, et al.
Published: (2012-10-01)

Pituitary Adenylate-Cyclase Activating Polypeptide Regulates Hunger- and Palatability-Induced Binge Eating
by: Matthew M. Hurley, et al.
Published: (2016-08-01)

Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin
by: Robert Gábriel, et al.
Published: (2019-10-01)

Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
by: Dingwei Ye, et al.
Published: (2023-12-01)

New insights into spexin and pituitary adenylate cyclase-activating polypeptide (PACAP) in regulating fish reproduction
by: Ashis Saha, et al.
Published: (2024-05-01)

New Evidence for the Role of Pituitary Adenylate Cyclase-Activating Polypeptide as an Antimicrobial Peptide in Teleost Fish
by: Janet Velázquez, et al.
Published: (2023-09-01)

Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
by: Faisal Mohammad Amin, et al.
Published: (2018-05-01)

Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide.
by: Somia Debbabi, et al.
Published: (2018-01-01)

Pituitary adenylate cyclase activating polypeptide modulates catecholamine storage and exocytosis in PC12 cells.
by: Yan Dong, et al.
Published: (2014-01-01)

Pituitary adenylate cyclase-activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelae.
by: Markus M Heimesaat, et al.
Published: (2014-01-01)

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-01-01)

Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-11-01)

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
by: Jiaqi Su, et al.
Published: (2022-10-01)

Role of pituitary adenylate cyclase-activating polypeptide in peripheral nerve regeneration: a cellular and molecular perspective
by: Grazia Maugeri, et al.
Published: (2024-01-01)

Presence of Systemic Amyloidosis in Mice with Partial Deficiency in Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Aging
by: Jason Sparks, et al.
Published: (2021-08-01)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
by: Casper Emil Christensen, et al.
Published: (2022-09-01)

Relationship between Plasma Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Level and Proteome Profile of Cows
by: Levente Czegledi, et al.
Published: (2022-06-01)

Immunohistochemical Study on the Innervation of the Chicken Pancreas by Pituitary Adenylate Cyclase-Activating Polypeptides (PACAPs)-Containing Nerves
by: Kohzy Hiramatsu, et al.
Published: (2009-07-01)

Pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment
by: Misaki Iwahashi, et al.
Published: (2023-11-01)